:: Library Catalog

Copertina

Salvato in:

Dettagli Bibliografici
Autori principali:	Sem Decani, Giulia Ghidini, Niccolò Lombardi, Laura Moneghini, Elena Maria Varoni
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	eJHaem
Accesso online:	https://onlinelibrary.wiley.com/doi/10.1002/jha2.1069
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Combination of reduced post‐transplant cyclophosphamide and early tacrolimus initiation increases the incidence of chronic graft‐versus‐host disease in human leukocyte antigen‐haploidentical peripheral blood stem‐cell transplantation
di: Toshiki Terao, et al.
Pubblicazione: (2024)

Graft‐versus‐host disease after autologous stem cell transplantation in a recipient who underwent allogeneic stem cell transplantation 20 years earlier
di: Osamu Imataki, et al.
Pubblicazione: (2024)

Successful treatment of low‐risk myelodysplastic syndrome‐related anemia in patients with chronic kidney disease with daprodustat: A report of two cases
di: Hiroyoshi Kunimoto, et al.
Pubblicazione: (2024)

Prophylactic versus on‐demand transfusion in pregnant women with sickle cell disease: A systematic review and meta‐analysis of randomised controlled trials
di: Denise Menezes Brunetta, et al.
Pubblicazione: (2025)

Immune profiling of responses to influenza vaccination in patients with myeloproliferative neoplasms
di: Petra Bachanová, et al.
Pubblicazione: (2024)

Medical history and lifestyle factors have limited impact on time‐to‐first‐treatment in patients with chronic lymphocytic leukemia
di: Ingrid Glimelius, et al.
Pubblicazione: (2024)

Angioimmunoblastic T‐cell lymphoma: Characterization of clonal T and B cells and a patient‐derived xenograft study of coexisting T‐ and B‐cell proliferation
di: Xiaoxian Zhao, et al.
Pubblicazione: (2025)

Mutant NPM1 marginally impacts ribosome footprint in acute myeloid leukemia cells
di: Lorenzo Brunetti, et al.
Pubblicazione: (2024)

Coinheritance of non‐deletional hemoglobin H disease with sickle cell trait
di: Veroniki Komninaka, et al.
Pubblicazione: (2024)

Routine hemostasis profile in steady state sickle cell disease adult patients compared to laboratory values, between phenotypes and during pregnancy: A retrospective, descriptive study
di: Comlan Affo, et al.
Pubblicazione: (2024)

Uptake of the first to fifth doses of coronavirus disease 2019 vaccine in individuals with chronic lymphocytic leukaemia: A nationwide cohort study in Sweden
di: Pontus Hedberg, et al.
Pubblicazione: (2025)

Intracytoplasmic inclusions in chronic lymphocytic leukemia cells of an elderly person living with human immunodeficiency virus and presenting with Richter transformation to Hodgkin lymphoma
di: Evashin Pillay, et al.
Pubblicazione: (2025)

Incidence, description, and timing of serious and opportunistic infections in patients with hairy cell leukemia
di: Nilesh Kapoor, et al.
Pubblicazione: (2024)

Extramedullary chronic phase chronic myeloid leukaemia (CML) involving the central nervous system: A case report
di: Akshay Deshpande, et al.
Pubblicazione: (2024)

Pneumonia in patients with chronic lymphocytic leukemia treated with venetoclax‐based regimens: A real‐world analysis of Polish Adult Leukemia Group (PALG)
di: Elżbieta Kalicińska, et al.
Pubblicazione: (2024)

Increased serum B‐cell maturation antigen levels evaluated with an Elecsys‐based serum B‐cell maturation antigen assay have a negative prognostic value in patients with newly diagnosed multiple myeloma
di: Evangelos Terpos, et al.
Pubblicazione: (2024)

Red blood cell transfusion and the use of intravenous iron in iron‐deficient patients presenting to the emergency department
di: Kevin Thomas, et al.
Pubblicazione: (2024)

Lisocabtagene maraleucel for treatment of relapsed and refractory primary mediastinal large B‐cell lymphoma in an adolescent patient
di: Dasom Lee, et al.
Pubblicazione: (2024)

IFN‐α treatment may enable discontinuation of TKIs in NK cell‐licensed patients with CML‐CP
di: Hiroshi Ureshino, et al.
Pubblicazione: (2024)

Successful treatment of refractory donor‐specific‐human leukocyte antigen‐antibody‐induced primary graft‐failure with daratumumab: A case report
di: Vadim Lesan, et al.
Pubblicazione: (2024)

CD58 expression does not impact response to inotuzumab ozogamicin in patients with B‐cell acute lymphoblastic leukemia
di: Rafael Madero‐Marroquin, et al.
Pubblicazione: (2024)

MicroRNAs: Potential prognostic and theranostic biomarkers in chronic lymphocytic leukemia
di: Afgar Ali, et al.
Pubblicazione: (2024)

Positive impacts of universal newborn screening on the outcome of children with sickle cell disease in the province of Quebec: A retrospective cohort study
di: Costa Kazadi, et al.
Pubblicazione: (2024)

Implications of acute coronavirus disease 2019 during haematopoietic stem cell transplantation—Experience from real‐world clinical practice
di: Christopher Shwei Wen Tham, et al.
Pubblicazione: (2024)

Real‐world outcomes of patients with relapsed/refractory large B‐cell lymphoma receiving second‐line therapy in England
di: Christopher P. Fox, et al.
Pubblicazione: (2024)

A phase 1 trial of venetoclax in combination with liposomal vincristine in patients with relapsed or refractory B‐cell or T‐cell acute lymphoblastic leukemia: Results from the ECOG‐ACRIN EA9152 protocol
di: Neil D. Palmisiano, et al.
Pubblicazione: (2024)

Concurrent hyperdiploid acute myeloid leukemia and trisomy 12+ chronic lymphocytic leukemia
di: Tulasi Geevar, et al.
Pubblicazione: (2024)

Aplastic anemia triggered by the Bruton tyrosine kinase inhibitor acalabrutinib in two patients with mantle cell lymphoma – A case report
di: Anna Nikkarinen, et al.
Pubblicazione: (2024)

Efficacy and manageable safety of tagraxofusp in blastic plasmacytoid dendritic cell neoplasm: a case series of pediatric and adolescent/young adult patients
di: Naveen Pemmaraju, et al.
Pubblicazione: (2024)

Severe acute respiratory syndrome coronavirus 2 infection in patients with hematological malignancies in the Omicron era: Respiratory failure, need for mechanical ventilation and mortality in seronegative and seropositive patients
di: Erica Franceschini, et al.
Pubblicazione: (2024)

Fludarabine, busulfan, and melphalan conditioning regimen in allogeneic hematopoietic stem cell transplantation for adult patients with myeloid malignancies: A multicenter retrospective study
di: Jieling Jiang, et al.
Pubblicazione: (2024)

TP53 variants underlying pediatric low‐hypodiploidy B‐cell acute lymphoblastic leukemia demonstrate diverse origins and may persist as a hematopoietic clone in remission
di: Albert Itov, et al.
Pubblicazione: (2024)

Unlocking the potential of synthetic patients for accelerating clinical trials: Results of the first GIMEMA experience on acute myeloid leukemia patients
di: Alfonso Piciocchi, et al.
Pubblicazione: (2024)

Outcomes of melphalan 140 mg/m2 followed by autologous stem cell transplantation in multiple myeloma patients with co‐morbidities: Single‐centre experience
di: Dario Melotti, et al.
Pubblicazione: (2024)

The association of donor and recipient sex on sepsis rates and hemoglobin increment among critically ill patients receiving red cell transfusions in a retrospective study
di: Wenhui Li, et al.
Pubblicazione: (2025)

CD4+ chronic lymphocytic leukemia in an 86‐year‐old male veteran: A case report
di: Sara Abdelrahim, et al.
Pubblicazione: (2024)

Real‐world characteristics and outcomes of patients with multiple myeloma receiving second‐line treatment in England
di: Sally Moore, et al.
Pubblicazione: (2024)

Successful treatment of acyclovir‐resistant herpes simplex virus infection with amenamevir in a patient who received umbilical cord blood transplantation for T‐cell prolymphocytic leukemia
di: Yuma Kawamura, et al.
Pubblicazione: (2024)

Establishing meaningful change thresholds for European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire CLL‐specific module domain scores: An analysis based on the TRANSCEND CLL 004 study in patients with relapsed or refractory chronic lymphocytic leukaemia or small lymphocytic lymphoma
di: Laurie Eliason, et al.
Pubblicazione: (2024)

A decade of chronic lymphocytic leukaemia therapy in Germany: Real‐world treatment patterns and outcomes (2010–2022)
di: Hannes Wartmann, et al.
Pubblicazione: (2024)